• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床阿片戒断量表(COWS)。

The Clinical Opiate Withdrawal Scale (COWS).

作者信息

Wesson Donald R, Ling Walter

机构信息

CNS Medications Development, Oakland, California, USA.

出版信息

J Psychoactive Drugs. 2003 Apr-Jun;35(2):253-9. doi: 10.1080/02791072.2003.10400007.

DOI:10.1080/02791072.2003.10400007
PMID:12924748
Abstract

The clinical opiate withdrawal scale (COWS) is a clinician-administered, pen and paper instrument that rates eleven common opiate withdrawal signs or symptoms. The summed score of the eleven items can be used to assess a patient's level of opiate withdrawal and to make inferences about their level of physical dependence on opioids. With increasing use of opioids for treatment of pain and the availability of sublingual buprenorphine in the United States for treatment of opioid dependence, clinical assessment of opiate withdrawal intensity has received renewed interest. Buprenorphine, a partial opiate agonist at the mu receptor, can precipitate opiate withdrawal in patients with a high level of opioid dependence who are not experiencing opioid withdrawal. Since development of the first opiate withdrawal scale in the mid-1930s, many different opioid withdrawal scales have been used in clinical and research settings. This article reviews the history of opiate withdrawal scales and the context of their initial use. A template version of the COWS that can be copied and used clinically is appended. PDF formatted versions of the COWS are also available from the websites of the American Society of Addiction Medicine, the California Society of Addiction Medicine, the UCLA Integrated Substance Abuse Programs, and AlcoholMD.com.

摘要

临床阿片类药物戒断量表(COWS)是一种由临床医生操作的纸笔式工具,用于对11种常见的阿片类药物戒断体征或症状进行评分。这11项的总分可用于评估患者的阿片类药物戒断水平,并推断其对阿片类药物的身体依赖程度。随着阿片类药物在疼痛治疗中的使用增加,以及美国舌下含服丁丙诺啡用于治疗阿片类药物依赖的可用性,阿片类药物戒断强度的临床评估重新受到关注。丁丙诺啡是μ受体的部分阿片类激动剂,可使未经历阿片类药物戒断的高阿片类药物依赖患者出现阿片类药物戒断症状。自20世纪30年代中期首个阿片类药物戒断量表问世以来,临床和研究环境中使用了许多不同的阿片类药物戒断量表。本文回顾了阿片类药物戒断量表的历史及其最初使用的背景。附录中提供了可复制并用于临床的COWS模板版本。美国成瘾医学协会、加利福尼亚成瘾医学协会、加州大学洛杉矶分校综合药物滥用项目以及AlcoholMD.com网站也提供PDF格式的COWS版本。

相似文献

1
The Clinical Opiate Withdrawal Scale (COWS).临床阿片戒断量表(COWS)。
J Psychoactive Drugs. 2003 Apr-Jun;35(2):253-9. doi: 10.1080/02791072.2003.10400007.
2
The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial.不同单剂量高剂量丁丙诺啡对伴有阿片类药物依赖的急性抑郁症患者自杀意念的疗效:一项随机、双盲临床试验。
Trials. 2018 Aug 29;19(1):462. doi: 10.1186/s13063-018-2843-9.
3
Educating Nurses on the Use of the Clinical Opiate Withdrawal Scale to Improve Care of Adult Patients Undergoing Buprenorphine Induction.培训护士使用临床阿片类药物戒断量表,以改善接受丁丙诺啡诱导的成年患者的护理。
J Addict Nurs. 2020 Oct/Dec;31(4):229-235. doi: 10.1097/JAN.0000000000000361.
4
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.临床阿片戒断量表(COWS)及单项指标与临床麻醉品评估(CINA)阿片戒断工具的同步效度验证。
Drug Alcohol Depend. 2009 Nov 1;105(1-2):154-9. doi: 10.1016/j.drugalcdep.2009.07.001. Epub 2009 Aug 3.
5
Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003.审视临床阿片戒断量表的因子结构:来自国家药物滥用治疗临床试验网络(CTN)0003的二次数据分析
Drug Alcohol Depend. 2015 Jul 1;152:218-23. doi: 10.1016/j.drugalcdep.2015.03.036. Epub 2015 Apr 11.
6
Single high-dose buprenorphine for opioid craving during withdrawal.单次大剂量丁丙诺啡用于戒断期间的阿片类药物渴求。
Trials. 2018 Dec 10;19(1):675. doi: 10.1186/s13063-018-3055-z.
7
Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria.根据《精神疾病诊断与统计手册》第三版修订版标准,诱发的阿片类药物戒断症状的严重程度可预测药物依赖。
Am J Drug Alcohol Abuse. 1989;15(3):237-50. doi: 10.3109/00952998908993405.
8
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.一项关于确定碾碎的缓释胶囊中吗啡和纳曲酮共同释放是否会导致阿片类药物依赖患者戒断反应的临床试验:6例患者的描述性分析
J Opioid Manag. 2013 Mar-Apr;9(2):139-50. doi: 10.5055/jom.2013.0155.
9
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.丁丙诺啡和一种促肾上腺皮质激素释放因子1拮抗剂可阻断大鼠中阿片类药物戒断诱导的条件性位置厌恶的形成。
Neuropsychopharmacology. 2005 Jan;30(1):90-8. doi: 10.1038/sj.npp.1300487.
10
Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.丁丙诺啡/纳洛酮在阿片类药物依赖患者中的安全性和疗效:一项意大利观察性研究。
Clin Drug Investig. 2010;30 Suppl 1:21-6. doi: 10.2165/11536010-000000000-00000.

引用本文的文献

1
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada.阿片类药物使用障碍患者阿片类激动剂替代初始剂量治疗的比较效果:一项在加拿大不列颠哥伦比亚省使用目标试验模拟的基于人群的回顾性研究方案
BMJ Open. 2025 Sep 1;15(9):e098990. doi: 10.1136/bmjopen-2025-098990.
2
Emergency Psychiatry in the General Adult Population: Clinical and Training Approaches.普通成年人群中的急诊精神病学:临床与培训方法
Can J Psychiatry. 2025 Sep 1:7067437251319904. doi: 10.1177/07067437251319904.
3
A self-assessment of opioid use disorder services at a Pacific Northwest County jail.
对太平洋西北地区一个县监狱的阿片类药物使用障碍服务的自我评估。
Subst Abuse Treat Prev Policy. 2025 Aug 13;20(1):31. doi: 10.1186/s13011-025-00667-5.
4
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial.快速静脉注射症状抑制性芬太尼诱导法(SIFI),以优化使用非正规芬太尼者向口服阿片类激动剂疗法的转换:一项开放标签、单臂临床试验方案
Addict Sci Clin Pract. 2025 Jul 29;20(1):58. doi: 10.1186/s13722-025-00586-7.
5
Biochemical Identification and Clinical Description of Medetomidine Exposure in People Who Use Fentanyl in Philadelphia, PA.宾夕法尼亚州费城使用芬太尼人群中咪达托咪定暴露的生化鉴定与临床描述
Int J Mol Sci. 2025 Jul 13;26(14):6715. doi: 10.3390/ijms26146715.
6
Medicines used in the treatment of opioid dependence.用于治疗阿片类药物依赖的药物。
Aust Prescr. 2025 Jun;48(3):98-105. doi: 10.18773/austprescr.2025.028.
7
Transcutaneous Cervical Vagus Nerve Stimulation Modulates Prefrontal Cortex Activity During Opioid Withdrawal in Individuals With Opioid Use Disorder.经皮颈迷走神经刺激调节阿片类物质使用障碍患者阿片类物质戒断期间的前额叶皮质活动。
Neuromodulation. 2025 Jun 23. doi: 10.1016/j.neurom.2025.04.012.
8
Neurocognitive Functions Among Patients Dependent on Natural Opium: A Comparative Cross-Sectional Study.依赖天然鸦片患者的神经认知功能:一项比较性横断面研究。
Cureus. 2025 May 22;17(5):e84621. doi: 10.7759/cureus.84621. eCollection 2025 May.
9
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical Trial.对感染住院患者启动注射用丁丙诺啡治疗:一项随机临床试验。
JAMA Netw Open. 2025 May 1;8(5):e2513000. doi: 10.1001/jamanetworkopen.2025.13000.
10
Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report.患者自行选择低剂量静脉注射纳洛酮用于快速丁丙诺啡诱导:一例病例报告。
Addict Sci Clin Pract. 2025 May 14;20(1):42. doi: 10.1186/s13722-025-00572-z.